.jpg)
STAT+: Former Verily executives hatch plan to invest millions in high-tech medical data
Two former Verily executives say that they are starting a new initiative, Highlander Health, to…
Category: Medicine
Q&A: Atsena Therapeutics’ gene therapy for inherited blindness shows promise
Seven years after the FDA approved Luxterna, scientists have yet to bring another congenital blindness…
Opinion: How much does it cost to give birth in the U.S.?
What does it cost to have a baby in the United States? This question has…
.jpg)
A race-free algorithm is merely the start for a safety net hospital confronting an onslaught of kidney disease
NEW YORK — One Brooklyn Health, a safety net hospital system that serves some of…
STAT+: House passes bill that targets China biotechs
WASHINGTON — The House Monday passed a bill by 306 to 81 votes to make…
Apple pushes into sleep apnea detection but health care integration remain unclear
CUPERTINO, Calif. — Apple on Monday announced a new Apple Watch feature that will warn…
STAT+: How powerful hospitals helped take R1 RCM private
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
With TV drug ads, what you see is not necessarily what you get
Triumphant music plays as cancer patients go camping, do some gardening, and watch fireworks in ads…
Terns’ GLP-1 pill leads to weight loss in early study
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about a Maryland law governing 340B discounts, an obesity drug, and more
The largest U.S. pharmaceutical industry trade group and several drug companies lost a bid to…
STAT+: Merck executive plays down impact of new lung cancer drug data on Keytruda
With strong data released over the weekend, an experimental Chinese drug showed it could one…
STAT+: RayzeBio, Dice alums raise $370 million for new autoimmune startup
After leading his previous company through a back-to-back IPO and M&A deal, the former chief…
STAT+: Highmark reboots coverage of digital treatments, raising hope among DTx companies
Highmark Health, a large regional health insurer that also owns a chain of hospitals, is…
STAT+: Relay discloses encouraging results for experimental breast cancer treatment
Relay Therapeutics disclosed encouraging results for its key breast cancer drug and plans to advance…
Biden administration finalizes rules to ensure insurers pay for mental health care
The Biden administration on Monday announced it would finalize a highly anticipated proposal meant to…
Medicine struggles to define chronic Lyme. Long Covid has only made it harder
Going to the doctor is already tricky enough for people with chronic symptoms of Lyme…
STAT+: With a win in lung cancer, biotech’s wealthiest outsider surfs to new heights
On Sunday, a small biotech company called Summit Therapeutics won a remarkable victory, saying its…
How Paralympic athletes are helping science learn more about neuropathic pain
Elite athletes train and compete under a watchful eye. Fans and coaches track and measure…
Opinion: How Pfizer ended up passing on my GLP-1 work back in the early ’90s
One of the biopharma industry’s marvels of the 2020s has been the enormous medical and…
Opinion: Breakthrough therapies have given Duchenne muscular dystrophy families like mine hope — and new fears
Duchenne muscular dystrophy has seen more progress in the past 15 months (give or take)…
She was told she might have cancer: How medicine pathologizes Black patients’ normal test results
A busy medical student, Vanessa Apea wasn’t her usual energetic self. So she dragged herself…
5 burning questions about Missouri’s mysterious H5 bird flu case
News that a person in Missouri contracted H5 bird flu despite having no known contact…
STAT+: Detailed data show Summit therapy beat Merck blockbuster Keytruda in late-stage lung cancer trial
SAN DIEGO — For years, Merck’s drug Keytruda has dominated cancer immunotherapy, racking up dozens…
Opinion: First Opinion readers on cancer screening, mpox vaccines, and more
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences…
Missouri resident who had no contact with animals tests positive for bird flu
This is a developing story and will be updated. A person in Missouri who didn’t…
STAT+: Dana-Farber’s Laurie Glimcher is leaving on her own terms. That’s the difference between male and female leadership.
Laurie Glimcher stunned Boston’s medical world last September by orchestrating Dana-Farber Cancer Institute’s breakup with its longtime…
STAT+: Ascension, other hospitals played active roles to take medical billing company R1 RCM private
Private equity firms are leading the buyout of R1 RCM, a major provider of billing…
Transparent mice and using zip codes to predict heart risk
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning…
STAT+: Pharmalittle: We’re reading about FDA inspections, Lilly insulin trial results, and more
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Gaza polio vaccination drive must include measles shots
We have each worked on childhood vaccination programs in both development and humanitarian emergency settings…
Opinion: Presidential debate moderators should ask about mental health policy
As the mom of three young adults, I am worried about their economic future —…
Upending a longstanding paradigm, cardiologists embrace ZIP codes, not race, to predict heart risk
Not only is Joseph Wright a physician, he’s the chief health equity officer for the…
STAT+: Vor Biopharma’s ‘shielded’ transplant delays relapse in leukemia patients
A CRISPR-augmented stem cell transplant that protects healthy cells from the toxic effects of anti-cancer…
In a first, living mice are made transparent
When a dye called tartrazine is added to food, it creates a bright yellow hue…
Summit’s upcoming cancer results, Recursion’s mixed data, and the next big obesity target
How effective is Summit Therapeutics’ lung cancer immunotherapy? Why are obesity drugmakers turning back to…
Youth vaping continues its tumble from a Juul-fueled high
The number of U.S. kids who are using e-cigarettes has continued to tumble, new federal…
STAT+: The battle over race in kidney function equations
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning…
Medicare claims data offer clues on doctors most likely to offer telehealth visits
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology…
STAT+: U.K. charities give $36 million to start new drugs for childhood tumors
For three decades, adults have benefited from a revolution in oncology treatment, as immunotherapies and…
Nearly 2,000 drug manufacturing plants are overdue for FDA inspections after Covid delays
Federal regulators responsible for the safety of the U.S. drug supply are still struggling to…
Lilly has more positive data on its weekly insulin
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about China detaining AstraZeneca staff, pharma layoffs, and more
Rise and shine, another busy day is on the way. However, this is also shaping…
STAT+: Summit Therapeutics vs. Merck: Prepping for a big lung cancer study reveal
Let’s set the table for Sunday’s presentation of the lung cancer immunotherapy trial known as…
STAT+: Alnylam versus BridgeBio: The ATTR-CM debate
I coined the term “Typo-gate” to describe the misguided dustup Alnylam Pharmaceuticals executives instigated last…
STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target
Nearly two decades ago, a small company called Amylin Pharmaceuticals saw that its first commercial…
Opinion: The truth behind that viral study on fluoride and IQ
A version of this essay first appeared in Jess Steier’s newsletter, “Unbiased Science.” Fluoride is…
Opinion: Eight former CDC directors: Hollowing out the CDC is a prescription for disaster
As former directors of the Centers for Disease Control and Prevention, we are deeply concerned…
Inside the bruising battle to purge race from a kidney disease calculator
There it was on James Cannon’s lab report, two tiny words: African American. The words…
STAT+: Humana cutting Medicare Advantage plans that cover 10% of members
Roughly 10% of people enrolled in Humana’s private Medicare plans will have to find new…
Depression: How brain scans helped predict long-term treatment outcomes
Depression has many faces. Some people can’t sleep, while others struggle to get out of…